ZBIO
Zenas BioPharma
ZBIO
ZBIO
117 hedge funds and large institutions have $1.5B invested in Zenas BioPharma in 2025 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
50% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 24
48% more funds holding
Funds holding: 79 → 117 (+38)
5.28% less ownership
Funds ownership: 82.7% → 77.43% (-5.3%)
Holders
117
Holding in Top 10
8
Calls
$9.75M
Puts
$6.4M
Top Buyers
| 1 | +$94.8M | |
| 2 | +$34.8M | |
| 3 | +$28.1M | |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$26M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$26M |
Top Sellers
| 1 | -$34.7M | |
| 2 | -$18.1M | |
| 3 | -$10.8M | |
| 4 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$6.15M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.37M |
